Fill and aspirate foam sclerotherapy (FAFS): a new approach for sclerotherapy of large superficial varicosities concomitant to endovenous laser ablation of truncal vein

Aim To define and assess the short-term clinical feasibility of fill and aspirate foam sclerotherapy (FAFS) for treating large superficial varicose veins concomitant to endovenous laser ablation (EVLA). Materials and methods Twenty-seven patients who refused to have phlebectomies with great saphenou...

Full description

Saved in:
Bibliographic Details
Published inClinical radiology Vol. 70; no. 1; pp. 48 - 53
Main Author Atasoy, M.M
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 01.01.2015
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Aim To define and assess the short-term clinical feasibility of fill and aspirate foam sclerotherapy (FAFS) for treating large superficial varicose veins concomitant to endovenous laser ablation (EVLA). Materials and methods Twenty-seven patients who refused to have phlebectomies with great saphenous vein reflux and large superficial varicosities were included in the study. Both EVLA and FAFS were performed concomitantly. FAFS is a technique in which all or most of the bubbles and blood–foam mixture are removed from the targeted large varicose veins immediately after the foam has caused sufficient damage to the endothelial cells. Patients were reviewed 1 month and 6 months after the treatment. Improvement in the clinical, aetiological, anatomical, and pathological classification (CEAP), and clinical severity was graded using the revised venous clinical severity score (rVCSS) and cosmetic results were investigated at the 6 month visit. Results Ablation of GSV was performed in 27 limbs in 27 patients (19 males, 70.3%; mean age 44 years; range 21–69 years). All patients had a technically successful FAFS treatment. The CEAP classification score, the rVCSS values, and the cosmetic results showed prominent improvement 6 months after the treatment. There were no significant complications, such as stroke, skin burns, necrosis, paresthesia, deep-vein thrombosis, or allergic reaction. None of the patients experienced neurological events. Conclusion FAFS is a promising safe and effective technique for treating large superficial varicosities concomitant to EVLA of the truncal veins with excellent clinical results. Randomized prospective studies with larger series are required to compare the FAFS with ambulatory phlebectomy and standard foam sclerotherapy.
AbstractList To define and assess the short-term clinical feasibility of fill and aspirate foam sclerotherapy (FAFS) for treating large superficial varicose veins concomitant to endovenous laser ablation (EVLA). Twenty-seven patients who refused to have phlebectomies with great saphenous vein reflux and large superficial varicosities were included in the study. Both EVLA and FAFS were performed concomitantly. FAFS is a technique in which all or most of the bubbles and blood-foam mixture are removed from the targeted large varicose veins immediately after the foam has caused sufficient damage to the endothelial cells. Patients were reviewed 1 month and 6 months after the treatment. Improvement in the clinical, aetiological, anatomical, and pathological classification (CEAP), and clinical severity was graded using the revised venous clinical severity score (rVCSS) and cosmetic results were investigated at the 6 month visit. Ablation of GSV was performed in 27 limbs in 27 patients (19 males, 70.3%; mean age 44 years; range 21-69 years). All patients had a technically successful FAFS treatment. The CEAP classification score, the rVCSS values, and the cosmetic results showed prominent improvement 6 months after the treatment. There were no significant complications, such as stroke, skin burns, necrosis, paresthesia, deep-vein thrombosis, or allergic reaction. None of the patients experienced neurological events. FAFS is a promising safe and effective technique for treating large superficial varicosities concomitant to EVLA of the truncal veins with excellent clinical results. Randomized prospective studies with larger series are required to compare the FAFS with ambulatory phlebectomy and standard foam sclerotherapy.
To define and assess the short-term clinical feasibility of fill and aspirate foam sclerotherapy (FAFS) for treating large superficial varicose veins concomitant to endovenous laser ablation (EVLA). Twenty-seven patients who refused to have phlebectomies with great saphenous vein reflux and large superficial varicosities were included in the study. Both EVLA and FAFS were performed concomitantly. FAFS is a technique in which all or most of the bubbles and blood–foam mixture are removed from the targeted large varicose veins immediately after the foam has caused sufficient damage to the endothelial cells. Patients were reviewed 1 month and 6 months after the treatment. Improvement in the clinical, aetiological, anatomical, and pathological classification (CEAP), and clinical severity was graded using the revised venous clinical severity score (rVCSS) and cosmetic results were investigated at the 6 month visit. Ablation of GSV was performed in 27 limbs in 27 patients (19 males, 70.3%; mean age 44 years; range 21–69 years). All patients had a technically successful FAFS treatment. The CEAP classification score, the rVCSS values, and the cosmetic results showed prominent improvement 6 months after the treatment. There were no significant complications, such as stroke, skin burns, necrosis, paresthesia, deep-vein thrombosis, or allergic reaction. None of the patients experienced neurological events. FAFS is a promising safe and effective technique for treating large superficial varicosities concomitant to EVLA of the truncal veins with excellent clinical results. Randomized prospective studies with larger series are required to compare the FAFS with ambulatory phlebectomy and standard foam sclerotherapy. •Fill and aspirate foam sclerotherapy (FAFS) is a easy and feasible alternative to the ambulatory phlebectomy for the treatment of large superficial varicose veins.•By using FAFS, foam can be prevented from passing into the deep veins.•By using FAFS, endothelium-derived biological mediators as well as the bubles are aspirated from the circulation and this may reduce systemic complications.•The DVT risk may also be decreased due to the aspiration of the pro-coagulant bloodfoam mixture.
Aim To define and assess the short-term clinical feasibility of fill and aspirate foam sclerotherapy (FAFS) for treating large superficial varicose veins concomitant to endovenous laser ablation (EVLA). Materials and methods Twenty-seven patients who refused to have phlebectomies with great saphenous vein reflux and large superficial varicosities were included in the study. Both EVLA and FAFS were performed concomitantly. FAFS is a technique in which all or most of the bubbles and blood–foam mixture are removed from the targeted large varicose veins immediately after the foam has caused sufficient damage to the endothelial cells. Patients were reviewed 1 month and 6 months after the treatment. Improvement in the clinical, aetiological, anatomical, and pathological classification (CEAP), and clinical severity was graded using the revised venous clinical severity score (rVCSS) and cosmetic results were investigated at the 6 month visit. Results Ablation of GSV was performed in 27 limbs in 27 patients (19 males, 70.3%; mean age 44 years; range 21–69 years). All patients had a technically successful FAFS treatment. The CEAP classification score, the rVCSS values, and the cosmetic results showed prominent improvement 6 months after the treatment. There were no significant complications, such as stroke, skin burns, necrosis, paresthesia, deep-vein thrombosis, or allergic reaction. None of the patients experienced neurological events. Conclusion FAFS is a promising safe and effective technique for treating large superficial varicosities concomitant to EVLA of the truncal veins with excellent clinical results. Randomized prospective studies with larger series are required to compare the FAFS with ambulatory phlebectomy and standard foam sclerotherapy.
AIMTo define and assess the short-term clinical feasibility of fill and aspirate foam sclerotherapy (FAFS) for treating large superficial varicose veins concomitant to endovenous laser ablation (EVLA).MATERIALS AND METHODSTwenty-seven patients who refused to have phlebectomies with great saphenous vein reflux and large superficial varicosities were included in the study. Both EVLA and FAFS were performed concomitantly. FAFS is a technique in which all or most of the bubbles and blood-foam mixture are removed from the targeted large varicose veins immediately after the foam has caused sufficient damage to the endothelial cells. Patients were reviewed 1 month and 6 months after the treatment. Improvement in the clinical, aetiological, anatomical, and pathological classification (CEAP), and clinical severity was graded using the revised venous clinical severity score (rVCSS) and cosmetic results were investigated at the 6 month visit.RESULTSAblation of GSV was performed in 27 limbs in 27 patients (19 males, 70.3%; mean age 44 years; range 21-69 years). All patients had a technically successful FAFS treatment. The CEAP classification score, the rVCSS values, and the cosmetic results showed prominent improvement 6 months after the treatment. There were no significant complications, such as stroke, skin burns, necrosis, paresthesia, deep-vein thrombosis, or allergic reaction. None of the patients experienced neurological events.CONCLUSIONFAFS is a promising safe and effective technique for treating large superficial varicosities concomitant to EVLA of the truncal veins with excellent clinical results. Randomized prospective studies with larger series are required to compare the FAFS with ambulatory phlebectomy and standard foam sclerotherapy.
Author Atasoy, M.M
Author_xml – sequence: 1
  fullname: Atasoy, M.M
BackLink https://www.ncbi.nlm.nih.gov/pubmed/25446324$$D View this record in MEDLINE/PubMed
BookMark eNp9ks1uEzEUhS1URNPCC7BAXpZFgv9mEiNUqapIQarEoiCxs27sO9RhYg-2JyhvxGPWoxQWXbCyrvSdI99z7hk5CTEgIa85W3DG23fbhU3gFoJxtWB6wbh8RmZcts1cCP39hMwYY3quRctOyVnO22lUQr0gp6JRqpVCzcifte97CsFRyINPUJB2EXY02x5TLPeYYDjQi_XV-u7tewo04G8Kw5Ai2PtKpidg7GgP6QfSPA6YOm899HQPyduYffGYqY3Bxp0vEAotkWJwcY8hjrkKMyYKmx6Kj2GyKmkMdjJAH16S5x30GV89vufk2_rj1-tP89svN5-vr27nVnFe5lxwtXTSOQd6s5FyJfVKLtFqZgXnorEKW2iFdqC6VrVcwGojQOqlUyvXNFqek4ujb93x14i5mJ3PFvseAtZfGt7KZbOUjIuKiiNqU8w5YWeG5HeQDoYzMzVktmZqyEwNGaZNbaiK3jz6j5sdun-Sv5VU4MMRwLrl3mMy2XoMFp1PaItx0f_f__KJ3PY--BrjTzxg3sYxhZqf4SYLw8zddBTTiXDFmFI1rAf8x7tl
CitedBy_id crossref_primary_10_1007_s12325_019_01011_7
Cites_doi 10.1258/phleb.2010.010030
10.1016/j.ejvs.2006.09.005
10.1016/j.jvsv.2012.10.040
10.1258/phleb.2012.012s09
10.1258/phleb.2011.010098
10.1016/j.ejvs.2013.07.013
10.1258/phleb.2009.009049
10.1177/0268355513483280
10.1016/j.jvs.2010.06.161
10.1007/s00270-012-0366-4
10.1258/phleb.2012.012051
ContentType Journal Article
Copyright The Royal College of Radiologists
2014 The Royal College of Radiologists
Copyright © 2014 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.
Copyright_xml – notice: The Royal College of Radiologists
– notice: 2014 The Royal College of Radiologists
– notice: Copyright © 2014 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.1016/j.crad.2014.09.013
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE


MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1365-229X
EndPage 53
ExternalDocumentID 10_1016_j_crad_2014_09_013
25446324
S0009926014004498
1_s2_0_S0009926014004498
Genre Journal Article
GroupedDBID ---
--K
--M
.1-
.55
.FO
.GJ
.~1
0R~
1B1
1P~
1RT
1~.
1~5
29B
3O-
4.4
457
4G.
53G
5GY
5RE
5VS
6PF
7-5
71M
8P~
9JM
AABNK
AACTN
AAEDT
AAEDW
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAWTL
AAXKI
AAXUO
ABBQC
ABFNM
ABJNI
ABMAC
ABMZM
ABXDB
ACDAQ
ACGFS
ACRLP
ADBBV
ADEZE
AEBSH
AEKER
AENEX
AEVXI
AFCTW
AFFNX
AFJKZ
AFKWA
AFRHN
AFTJW
AFXIZ
AGHFR
AGUBO
AGYEJ
AHHHB
AIEXJ
AIKHN
AITUG
AJOXV
AJRQY
AJUYK
AKRWK
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ANZVX
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
CAG
COF
CS3
DU5
EBS
EFJIC
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HEI
HMK
HMO
HVGLF
HZ~
IHE
J1W
J5H
K-O
KOM
M27
M41
MO0
N9A
O-L
O9-
OAUVE
OI~
OU0
OVD
OZT
P-8
P-9
P2P
PC.
Q38
R2-
RIG
ROL
RPZ
SAE
SCC
SDF
SDG
SDP
SEL
SES
SEW
SPCBC
SSH
SSZ
T5K
TEORI
UHS
UV1
WH7
WUQ
X7M
Z5R
ZGI
ZXP
~G-
AAIAV
ABLVK
ABYKQ
AHPSJ
AJBFU
EFLBG
LCYCR
ZA5
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c411t-12147d3ddda9bb33839837ec90c21125c4e6a629da4f64612a8b2a397d48d5593
IEDL.DBID AIKHN
ISSN 0009-9260
IngestDate Fri Oct 25 05:11:01 EDT 2024
Thu Sep 26 15:41:33 EDT 2024
Sat Sep 28 08:06:38 EDT 2024
Fri Feb 23 02:24:30 EST 2024
Tue Oct 15 14:33:59 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License Copyright © 2014 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c411t-12147d3ddda9bb33839837ec90c21125c4e6a629da4f64612a8b2a397d48d5593
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 25446324
PQID 1637573012
PQPubID 23479
PageCount 6
ParticipantIDs proquest_miscellaneous_1637573012
crossref_primary_10_1016_j_crad_2014_09_013
pubmed_primary_25446324
elsevier_sciencedirect_doi_10_1016_j_crad_2014_09_013
elsevier_clinicalkeyesjournals_1_s2_0_S0009926014004498
PublicationCentury 2000
PublicationDate 2015-01-01
PublicationDateYYYYMMDD 2015-01-01
PublicationDate_xml – month: 01
  year: 2015
  text: 2015-01-01
  day: 01
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Clinical radiology
PublicationTitleAlternate Clin Radiol
PublicationYear 2015
Publisher Elsevier Ltd
Publisher_xml – name: Elsevier Ltd
References Fattahi (bib5) 2013; 1
Parsi (bib11) 2011; 26
Breu, Guggenbichler, Wollmann (bib10) 2008; 37
Parsi (bib3) 2012; 27
Yilmaz, Ceken, Alimoglu (bib7) 2013; 36
Cameron, Chen, Connor (bib13) 2013; 46
Imhoff, Stemmer (bib14) 1969; 22
Guexx (bib9) 2009; 24
Willenberg, C Smith, Shepherd (bib4) 2013
Cavezzi, Parsi (bib1) 2012; 27
Vasquez, Rabe, McLafferty (bib6) 2010; 52
Rabe, Breu, Cavezzi (bib8) 2013; 29
Connor, Joseph, Exner (bib2) 2013
Myers, Jolley, Clough (bib12) 2007; 33
Rabe (10.1016/j.crad.2014.09.013_bib8) 2013; 29
Cameron (10.1016/j.crad.2014.09.013_bib13) 2013; 46
Vasquez (10.1016/j.crad.2014.09.013_bib6) 2010; 52
Parsi (10.1016/j.crad.2014.09.013_bib11) 2011; 26
Imhoff (10.1016/j.crad.2014.09.013_bib14) 1969; 22
Guexx (10.1016/j.crad.2014.09.013_bib9) 2009; 24
Yilmaz (10.1016/j.crad.2014.09.013_bib7) 2013; 36
Cavezzi (10.1016/j.crad.2014.09.013_bib1) 2012; 27
Breu (10.1016/j.crad.2014.09.013_bib10) 2008; 37
Willenberg (10.1016/j.crad.2014.09.013_bib4) 2013
Fattahi (10.1016/j.crad.2014.09.013_bib5) 2013; 1
Connor (10.1016/j.crad.2014.09.013_bib2) 2013
Parsi (10.1016/j.crad.2014.09.013_bib3) 2012; 27
Myers (10.1016/j.crad.2014.09.013_bib12) 2007; 33
References_xml – volume: 52
  start-page: 1387
  year: 2010
  end-page: 1396
  ident: bib6
  article-title: Revision of the venous clinical severity score: venous outcomes consensus statement: special communication of the American VenousForum Ad Hoc Outcomes Working Group
  publication-title: J Vasc Surg
  contributor:
    fullname: McLafferty
– volume: 27
  start-page: 46
  year: 2012
  end-page: 51
  ident: bib1
  article-title: Complications of foam sclerotherapy
  publication-title: Phlebology
  contributor:
    fullname: Parsi
– volume: 37
  start-page: 1
  year: 2008
  end-page: 29
  ident: bib10
  article-title: 2nd European consensus Meeting on Foam Sclerotherapy 2006, Tegernsee, Germany
  publication-title: Vasa
  contributor:
    fullname: Wollmann
– volume: 1
  start-page: 111
  year: 2013
  end-page: 112
  ident: bib5
  article-title: Foam washout sclerotherapy: a new technique geared toward reducing short- and long-term complications of regular foam sclerotherapy and comparison with existing foam sclerotherapy method
  publication-title: J Vasc Surg Venous Lymph Dısord
  contributor:
    fullname: Fattahi
– volume: 24
  start-page: 270
  year: 2009
  end-page: 274
  ident: bib9
  article-title: Complications and side-effects of foam sclerotherapy
  publication-title: Phlebology
  contributor:
    fullname: Guexx
– volume: 33
  start-page: 116
  year: 2007
  end-page: 121
  ident: bib12
  article-title: Outcome of ultrasound guided sclerotherapy for varicose veins: medium-term results assessed by ultrasound surveillance
  publication-title: Eur J Vasc Endovasc Surg
  contributor:
    fullname: Clough
– volume: 22
  start-page: 143
  year: 1969
  ident: bib14
  article-title: Classification and mechanism of action of sclerosing agents
  publication-title: Soc Fran Phlebol
  contributor:
    fullname: Stemmer
– year: 2013
  ident: bib4
  article-title: Visual disturbance following sclerotherapy for varicose veins, reticular veins and telangiectasias: a systematic literature review
  publication-title: Phlebology
  contributor:
    fullname: Shepherd
– volume: 46
  start-page: 488
  year: 2013
  end-page: 494
  ident: bib13
  article-title: Sclerosant foam structure and stability is strongly influenced by liquid air fraction
  publication-title: Eur J Vasc Endovasc Surg
  contributor:
    fullname: Connor
– volume: 36
  start-page: 150
  year: 2013
  end-page: 157
  ident: bib7
  article-title: US-guided femoral and sciatic nerve blocks for analgesia during endovenous laser ablation
  publication-title: Cardiovasc Intervent Radiol
  contributor:
    fullname: Alimoglu
– volume: 27
  start-page: 147
  year: 2012
  end-page: 167
  ident: bib3
  article-title: Paradoxical embolism, stroke and sclerotherapy
  publication-title: Phlebology
  contributor:
    fullname: Parsi
– year: 2013
  ident: bib2
  article-title: Infusion of foam sclerosants results in a distance-dependent procoagulant activity, haemoconcentration and elevation of D-dimer levels
  publication-title: Phlebology
  contributor:
    fullname: Exner
– volume: 29
  start-page: 338
  year: 2013
  end-page: 354
  ident: bib8
  article-title: European guidelines for sclerotherapy in chronic venous disorders
  publication-title: Phlebology
  contributor:
    fullname: Cavezzi
– volume: 26
  start-page: 140
  year: 2011
  end-page: 147
  ident: bib11
  article-title: Venous gas embolism during foam sclerotherapy of saphenous veins despite recommended treatment modifications
  publication-title: Phlebology
  contributor:
    fullname: Parsi
– volume: 22
  start-page: 143
  year: 1969
  ident: 10.1016/j.crad.2014.09.013_bib14
  article-title: Classification and mechanism of action of sclerosing agents
  publication-title: Soc Fran Phlebol
  contributor:
    fullname: Imhoff
– volume: 26
  start-page: 140
  year: 2011
  ident: 10.1016/j.crad.2014.09.013_bib11
  article-title: Venous gas embolism during foam sclerotherapy of saphenous veins despite recommended treatment modifications
  publication-title: Phlebology
  doi: 10.1258/phleb.2010.010030
  contributor:
    fullname: Parsi
– volume: 33
  start-page: 116
  year: 2007
  ident: 10.1016/j.crad.2014.09.013_bib12
  article-title: Outcome of ultrasound guided sclerotherapy for varicose veins: medium-term results assessed by ultrasound surveillance
  publication-title: Eur J Vasc Endovasc Surg
  doi: 10.1016/j.ejvs.2006.09.005
  contributor:
    fullname: Myers
– year: 2013
  ident: 10.1016/j.crad.2014.09.013_bib2
  article-title: Infusion of foam sclerosants results in a distance-dependent procoagulant activity, haemoconcentration and elevation of D-dimer levels
  publication-title: Phlebology
  contributor:
    fullname: Connor
– volume: 1
  start-page: 111
  year: 2013
  ident: 10.1016/j.crad.2014.09.013_bib5
  article-title: Foam washout sclerotherapy: a new technique geared toward reducing short- and long-term complications of regular foam sclerotherapy and comparison with existing foam sclerotherapy method
  publication-title: J Vasc Surg Venous Lymph Dısord
  doi: 10.1016/j.jvsv.2012.10.040
  contributor:
    fullname: Fattahi
– volume: 37
  start-page: 1
  issue: Suppl. 71
  year: 2008
  ident: 10.1016/j.crad.2014.09.013_bib10
  article-title: 2nd European consensus Meeting on Foam Sclerotherapy 2006, Tegernsee, Germany
  publication-title: Vasa
  contributor:
    fullname: Breu
– volume: 27
  start-page: 46
  year: 2012
  ident: 10.1016/j.crad.2014.09.013_bib1
  article-title: Complications of foam sclerotherapy
  publication-title: Phlebology
  doi: 10.1258/phleb.2012.012s09
  contributor:
    fullname: Cavezzi
– volume: 27
  start-page: 147
  year: 2012
  ident: 10.1016/j.crad.2014.09.013_bib3
  article-title: Paradoxical embolism, stroke and sclerotherapy
  publication-title: Phlebology
  doi: 10.1258/phleb.2011.010098
  contributor:
    fullname: Parsi
– volume: 46
  start-page: 488
  year: 2013
  ident: 10.1016/j.crad.2014.09.013_bib13
  article-title: Sclerosant foam structure and stability is strongly influenced by liquid air fraction
  publication-title: Eur J Vasc Endovasc Surg
  doi: 10.1016/j.ejvs.2013.07.013
  contributor:
    fullname: Cameron
– volume: 24
  start-page: 270
  year: 2009
  ident: 10.1016/j.crad.2014.09.013_bib9
  article-title: Complications and side-effects of foam sclerotherapy
  publication-title: Phlebology
  doi: 10.1258/phleb.2009.009049
  contributor:
    fullname: Guexx
– volume: 29
  start-page: 338
  year: 2013
  ident: 10.1016/j.crad.2014.09.013_bib8
  article-title: European guidelines for sclerotherapy in chronic venous disorders
  publication-title: Phlebology
  doi: 10.1177/0268355513483280
  contributor:
    fullname: Rabe
– volume: 52
  start-page: 1387
  year: 2010
  ident: 10.1016/j.crad.2014.09.013_bib6
  article-title: Revision of the venous clinical severity score: venous outcomes consensus statement: special communication of the American VenousForum Ad Hoc Outcomes Working Group
  publication-title: J Vasc Surg
  doi: 10.1016/j.jvs.2010.06.161
  contributor:
    fullname: Vasquez
– volume: 36
  start-page: 150
  year: 2013
  ident: 10.1016/j.crad.2014.09.013_bib7
  article-title: US-guided femoral and sciatic nerve blocks for analgesia during endovenous laser ablation
  publication-title: Cardiovasc Intervent Radiol
  doi: 10.1007/s00270-012-0366-4
  contributor:
    fullname: Yilmaz
– year: 2013
  ident: 10.1016/j.crad.2014.09.013_bib4
  article-title: Visual disturbance following sclerotherapy for varicose veins, reticular veins and telangiectasias: a systematic literature review
  publication-title: Phlebology
  doi: 10.1258/phleb.2012.012051
  contributor:
    fullname: Willenberg
SSID ssj0009424
Score 2.1232874
Snippet Aim To define and assess the short-term clinical feasibility of fill and aspirate foam sclerotherapy (FAFS) for treating large superficial varicose veins...
To define and assess the short-term clinical feasibility of fill and aspirate foam sclerotherapy (FAFS) for treating large superficial varicose veins...
AIMTo define and assess the short-term clinical feasibility of fill and aspirate foam sclerotherapy (FAFS) for treating large superficial varicose veins...
SourceID proquest
crossref
pubmed
elsevier
SourceType Aggregation Database
Index Database
Publisher
StartPage 48
SubjectTerms Adult
Aged
Feasibility Studies
Female
Humans
Laser Therapy - methods
Male
Middle Aged
Radiology
Retrospective Studies
Saphenous Vein - surgery
Sclerotherapy - methods
Treatment Outcome
Varicose Veins - therapy
Young Adult
Title Fill and aspirate foam sclerotherapy (FAFS): a new approach for sclerotherapy of large superficial varicosities concomitant to endovenous laser ablation of truncal vein
URI https://www.clinicalkey.es/playcontent/1-s2.0-S0009926014004498
https://dx.doi.org/10.1016/j.crad.2014.09.013
https://www.ncbi.nlm.nih.gov/pubmed/25446324
https://search.proquest.com/docview/1637573012
Volume 70
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB61Wwn1gniWpVC5EgcQCl0nTjbmtqqIFqr2ApV6s_yKlGpJVpulEpf-nv7MzqydIkDlwDGRH4lnPA975huAN1lNl2EFYexbmwh0vxKZp0XCDWpjXXhR15QofHpWzM_Fl4v8YguOh1wYCquMsj_I9I20jm-O4moeLZuGcnzRuiFELGJDIctt2EF1lJYj2Jl9Ppmf_cLeFakYCqpRh5g7E8K87EoTYCgPcKc8u08_3Wd_bvRQ9QgeRgOSzcI3PoYt3z6BB6fxivwp3FTNYsF065gOl-ie1Z3-znpsvYrpVj_Z22pWfX33kWmGZjUbgMWx5eqPhl3NFhQszvofSypoTSfs7AodbLuJ9vI9Q4caF6-hasRs3THfuu5qA_yKHZG_mTYh3I6GWq9QjdIAvmmfwXn16dvxPInlGBIrOF8nnEoaucw5p6Ux5NpK9G69lROLXmSaW-ELXaTSaVEXAi0nXZpUo73jROnQccmew6jtWv8CcObCWj-1dakz4SfO1JnJMy3l1AjDuRzD-4EIahlQN9QQjnapiGSKSKYmUiHJxjAd6KSGfFKUgL6P27FXXPWpmqi_WGYM-V3P37hOoUL554yHAzso3I50x6Jbjyur0Lyd5iQ10zHsBT65-wNCgyN0_Jf_Oes-7OJTHg6AXsEIaeZfo0m0Ngew_eGaH0TGvwWvSgwG
link.rule.ids 315,783,787,4509,24128,27936,27937,45597,45691
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwED-NTQJeEOOzwDYj8QBC0erESWveqmlRx9a-sEl7s_wVKagkVVMm8R_xZ3JXO0MwbQ97be249Z3vfhff_Q7gQ1bRZVhBHPvWJgLDr0TmaZFwg95YF15UFRUKz-bF9EJ8vcwvt-Cor4WhtMpo-4NN31jr-Mlh3M3DZV1TjS-iG2LEIjUUcvwAdhANSDydO5OT0-n8L_euSEXfUI0mxNqZkOZlV5oIQ3mgO-XZbf7pNvy58UPlU3gSASSbhN-4C1u-eQYPZ_GK_Dn8LuvFgunGMR0u0T2rWv2DdTh6FcutfrGP5aT89ukL0wxhNeuJxXHk6r-BbcUWlCzOup9LamhNb9jZFQbYdpPt5TuGATVuXk3diNm6Zb5x7dWG-BUnon4zbUK6HT1qvUI3Sg_wdfMCLsrj86NpEtsxJFZwvk44tTRymXNOS2MotJUY3XorhxajyDS3whe6SKXToioEIic9NqlGvOPE2GHgkr2E7aZt_GvAlQtr_chWY50JP3SmykyeaSlHRhjO5QA-90JQy8C6ofp0tO-KRKZIZGooFYpsAKNeTqqvJ0UL6Lt4HDvFVZeqobqhMgPIr2f-o3UKHcqdK77v1UHhcaQ7Ft143FmF8HaUk9VMB_Aq6Mn1PyA2OGLHf3PPVQ_g0fR8dqbOTuanb-ExfpOHl0HvYBvl5_cQHq3NflT_Pyj0Dfo
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Fill+and+aspirate+foam+sclerotherapy+%28FAFS%29%3A+a+new+approach+for+sclerotherapy+of+large+superficial+varicosities+concomitant+to+endovenous+laser+ablation+of+truncal+vein&rft.jtitle=Clinical+radiology&rft.au=Atasoy%2C+M.M&rft.date=2015-01-01&rft.issn=0009-9260&rft.volume=70&rft.issue=1&rft.spage=48&rft.epage=53&rft_id=info:doi/10.1016%2Fj.crad.2014.09.013&rft.externalDBID=ECK1-s2.0-S0009926014004498&rft.externalDocID=1_s2_0_S0009926014004498
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F00099260%2FS0009926014X00139%2Fcov150h.gif